Journal ArticleAliment Pharmacol Ther · August 2020
BACKGROUND: Patients with non-alcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease, are at higher risk of cardiovascular disease (CVD) and associated mortality. Therefore, it is important to understand how new therapies for ...
Full textLink to itemCite
Journal ArticleJournal of the Endocrine Society · May 8, 2020
AbstractImmune checkpoint inhibitors (ICI) specifically target and dysregulate immune tolerance. As a result of this immune activation, immune related adverse events (irAEs) are common. These can include end ...
Full textCite
Journal ArticleBMJ Case Rep · January 24, 2018
We report a 55-year-old man with gouty arthritis who developed a 3-month history of low back pain, gradual lower extremities weakness and urinary incontinence. Lumbar MRI showed an exophytic lesion at L3-L4. Immediately after spinal decompression surgery, ...
Full textLink to itemCite